-
111.
公开(公告)号:AU733759B2
公开(公告)日:2001-05-24
申请号:AU2397399
申请日:1999-04-26
Applicant: COR THERAPEUTICS INC
Inventor: SUNDELIN JOHAN ATLES GR , SCARBOROUGH ROBERT M
-
公开(公告)号:AU7486600A
公开(公告)日:2001-04-17
申请号:AU7486600
申请日:2000-09-15
Applicant: COR THERAPEUTICS INC
Inventor: ZHU BING-YAN , JIA ZHAOZHONG JON , HUANG WENRONG , SONG YONGHONG , KANTER JAMES , SCARBOROUGH ROBERT M JR
IPC: C07D231/14 , A61K31/33 , A61K31/415 , A61K31/4155 , A61K31/4178 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61P7/02 , A61P7/04 , A61P43/00 , C07C311/16 , C07C311/46 , C07C317/40 , C07C317/44 , C07D213/75 , C07D213/81 , C07D213/82 , C07D217/22 , C07D277/20 , C07D277/56 , C07D333/38 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D521/00 , C07D231/00
-
公开(公告)号:AU730864B2
公开(公告)日:2001-03-15
申请号:AU7458696
申请日:1996-10-18
Applicant: COR THERAPEUTICS INC
Inventor: PHILIPS DAVID , LAW DEBBIE A , ALAIMO LISA N
IPC: G01N33/53 , A61K38/00 , A61K45/00 , A61P7/02 , A61P9/00 , A61P29/00 , A61P35/00 , A61P43/00 , C07K14/705 , C12N5/06 , C12N11/02 , C12N15/09 , A61K39/00 , A61K39/38 , G01N33/574 , A01N37/18
Abstract: The present invention discloses that phosphorylation of cytoplasmic tyrosine residues in the beta-subunit of integrins is needed for signal protein association. The invention provides methods of identifying signaling partners involved in integrin mediated signaling, methods of identifying agents which block integrin mediated signaling, methods of using agents which block integrin mediated signaling to modulate biological and pathological processes, and agents which block integrin mediated signaling.
-
公开(公告)号:AU6762400A
公开(公告)日:2001-03-13
申请号:AU6762400
申请日:2000-08-10
Applicant: COR THERAPEUTICS INC
Inventor: ZHU BING-YAN , SCARBOROUGH ROBERT M JR , CLIZBE LANE , DOUGHAN BRANDON , JIA ZHAOZHONG-JON , KANE-MAGUIRE KIM , MARLOWE CHARLES , SONG YONGHONG , SU TING , TENG WILLY , ZHANG PENGLIE
IPC: C07D209/08 , C07D209/34 , C07D209/38 , C07D215/08 , C07D215/22 , C07D215/227 , C07D231/56 , C07D235/06 , C07D235/26 , C07D241/38 , C07D241/44 , C07D243/24 , C07D265/36 , C07D401/06 , C07D401/10 , C07D401/14 , C07D403/06 , C07D403/12 , C07D403/14 , C07D409/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D209/04 , C07D215/00 , C07D235/04 , C07D241/36 , C07D403/02 , C07D498/02
-
公开(公告)号:DE69328104T2
公开(公告)日:2000-12-21
申请号:DE69328104
申请日:1993-07-08
Applicant: COR THERAPEUTICS INC
Inventor: SCARBOROUGH ROBERT M
-
公开(公告)号:AU5723500A
公开(公告)日:2000-12-12
申请号:AU5723500
申请日:2000-05-24
Applicant: COR THERAPEUTICS INC
Inventor: SU TING , ZHU BING-YAN , KANE-MAGUIRE KIM , SCARBOROUGH ROBERT M JR , ZHANG PENGLIE
IPC: C07D213/74 , A61K31/18 , A61K31/198 , A61K31/341 , A61K31/397 , A61K31/40 , A61K31/401 , A61K31/4164 , A61K31/44 , A61K31/4406 , A61K31/4427 , A61K31/4453 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/5375 , A61K31/55 , A61P7/02 , A61P9/00 , A61P9/10 , A61P43/00 , C07C311/16 , C07C311/21 , C07C311/46 , C07D205/04 , C07D207/16 , C07D207/20 , C07D207/325 , C07D213/40 , C07D213/64 , C07D213/72 , C07D213/75 , C07D213/82 , C07D217/22 , C07D231/12 , C07D233/68 , C07D295/18 , C07D295/192 , C07D295/22 , C07D295/26 , C07D307/38 , C07D307/52 , C07D401/12 , A61K31/277 , A61K31/501
-
公开(公告)号:AU5284000A
公开(公告)日:2000-12-12
申请号:AU5284000
申请日:2000-05-24
Applicant: COR THERAPEUTICS INC
Inventor: ZHU BING-YAN , SCARBOROUGH ROBERT M JR , WANG LINGYAN
IPC: A61K31/155 , A61K31/18 , A61K31/275 , A61K31/401 , A61K31/402 , A61K31/451 , A61P7/02 , A61P9/00 , A61P9/04 , A61P9/10 , C07C311/46 , C07D207/16 , C07D211/60 , C07D241/04 , C07D243/08 , C07D401/04 , C07D403/04 , C07D413/04 , C07D207/00
-
公开(公告)号:AU5283800A
公开(公告)日:2000-12-12
申请号:AU5283800
申请日:2000-05-24
Applicant: COR THERAPEUTICS INC
Inventor: SU TING , ZHU BING-YAN , KANE-MAGUIRE KIM , SCARBOROUGH ROBERT M JR , ZHANG PENGLIE
IPC: C07D213/74 , A61K31/18 , A61K31/198 , A61K31/341 , A61K31/397 , A61K31/40 , A61K31/401 , A61K31/4164 , A61K31/44 , A61K31/4406 , A61K31/4427 , A61K31/4453 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/5375 , A61K31/55 , A61P7/02 , A61P9/00 , A61P9/10 , A61P43/00 , C07C311/16 , C07C311/21 , C07C311/46 , C07D205/04 , C07D207/16 , C07D207/20 , C07D207/325 , C07D213/40 , C07D213/64 , C07D213/72 , C07D213/75 , C07D213/82 , C07D217/22 , C07D231/12 , C07D233/68 , C07D295/18 , C07D295/192 , C07D295/22 , C07D295/26 , C07D307/38 , C07D307/52 , C07D401/12 , A61K31/33 , C07D207/22 , C07D207/32
-
公开(公告)号:AU5283700A
公开(公告)日:2000-12-12
申请号:AU5283700
申请日:2000-05-24
Applicant: COR THERAPEUTICS INC
Inventor: SONG YONGHONG , CLIZBE LANE , MARLOWE CHARLES , SCARBOROUGH ROBERT M JR , SU TING , ZHU BING-YAN
IPC: C07D233/61 , A61K31/165 , A61K31/167 , A61K31/18 , A61K31/198 , A61K31/216 , A61K31/277 , A61K31/341 , A61K31/40 , A61K31/404 , A61K31/415 , A61K31/422 , A61K31/4402 , A61K31/472 , A61K33/22 , A61P7/02 , A61P7/04 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P43/00 , C07C311/46 , C07C317/32 , C07D209/08 , C07D213/56 , C07D217/22 , C07D231/12 , C07D295/16 , C07D307/54 , C07D307/68 , C07D413/04 , C07D521/00
-
公开(公告)号:CA2374820A1
公开(公告)日:2000-11-30
申请号:CA2374820
申请日:2000-05-24
Applicant: COR THERAPEUTICS INC
Inventor: CLIZBE LANE , SONG YONGHONG , ZHU BING-YAN , KANTER JAMES , MARLOWE CHARLES , SU TING , SCARBOROUGH ROBERT M
IPC: C07D233/61 , A61K31/165 , A61K31/167 , A61K31/18 , A61K31/198 , A61K31/216 , A61K31/277 , A61K31/341 , A61K31/40 , A61K31/404 , A61K31/415 , A61K31/422 , A61K31/4402 , A61K31/472 , A61K33/22 , A61P7/02 , A61P7/04 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P43/00 , C07C311/46 , C07C317/32 , C07D209/08 , C07D213/56 , C07D217/22 , C07D231/12 , C07D295/16 , C07D307/54 , C07D307/68 , C07D413/04 , C07D521/00
Abstract: The present application relates to compounds of the general formula A-Y-D-E- G- J-Z-L, wherein A, Y, D, E, G, J, Z and L have the meanings given in the description, having activity against mammalian factor Xa. The compounds are useful in vitroor in vivofor preventing or treating coagulation disorders.
-
-
-
-
-
-
-
-
-